Victoza
Liraglutide · Novo Nordisk
Victoza (liraglutide) is a daily injectable GLP-1 for type 2 diabetes. It was one of the earliest GLP-1 medications and has extensive long-term safety data.
FDA-Approved Uses
Victoza is FDA-approved for the following conditions.
Dosing: 0.6mg, 1.2mg, or 1.8mg daily injection
Average Cost
What you can expect to pay for Victoza.
Need help affording Victoza?
Answer 9 questions. See every program you're eligible for. Free.
Medicaid Coverage by State
Victoza coverage status across all 51 states and territories.
| State | Medicaid | Medicare | Prior Auth |
|---|---|---|---|
| Alabama | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Alaska | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Arizona | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Arkansas | Covered (Prior Auth) | Covered (Prior Auth) | No |
| California | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Colorado | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Connecticut | Covered | Covered (Prior Auth) | No |
| Delaware | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| District of Columbia | Covered | Covered (Prior Auth) | No |
| Florida | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Georgia | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Hawaii | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Idaho | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Illinois | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Indiana | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Iowa | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Kansas | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Kentucky | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Louisiana | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Maine | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Maryland | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Massachusetts | Covered | Covered (Prior Auth) | No |
| Michigan | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Minnesota | Covered | Covered (Prior Auth) | No |
| Mississippi | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Missouri | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Montana | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Nebraska | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Nevada | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| New Hampshire | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| New Jersey | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| New Mexico | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| New York | Covered | Covered (Prior Auth) | No |
| North Carolina | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| North Dakota | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Ohio | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Oklahoma | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Oregon | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Pennsylvania | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Rhode Island | Covered | Covered (Prior Auth) | No |
| South Carolina | Covered (Prior Auth) | Covered (Prior Auth) | No |
| South Dakota | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Tennessee | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Texas | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Utah | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Vermont | Covered | Covered (Prior Auth) | No |
| Virginia | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Washington | Covered | Covered (Prior Auth) | No |
| West Virginia | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Wisconsin | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Wyoming | Covered (Prior Auth) | Covered (Prior Auth) | No |
Patient Assistance Programs
Novo Nordisk offers savings programs that may reduce your cost to $0. Check eligibility below.
Check Eligibility at Novo Nordisk ↗Victoza Side Effects
Common and serious side effects to discuss with your doctor.
⚡ Common Side Effects
- Nauseacommon
- Diarrheacommon
- Headachecommon
- Vomitinguncommon
⚠️ Serious Side Effects
- Pancreatitisrare
- Thyroid tumorsrare
Seek immediate medical attention if you experience any serious side effects.
Monitor Side Effects
Track Victoza Side Effects with Helix
Oura-style monitoring for your Victoza journey. Log side effects, see trends over time, and share reports with your doctor.
Try Helix Free →Free side effect tracking
Track Your Victoza Journey
Meet Enzo — Your GLP-1 Companion
A virtual pet that grows as you track your Victoza doses, weight, and meals. Stay motivated with streaks, milestones, and a buddy who celebrates your progress.
Try Enzo Free →Free on iOS and Android
Frequently Asked Questions
How much does Victoza cost without insurance?
Victoza costs approximately $970 per month without insurance. With insurance, copays range from $25 to $150 per month.
Does Medicaid cover Victoza?
Medicaid coverage for Victoza varies by state. Many states cover it with prior authorization. See the coverage table below for your state.
What are the side effects of Victoza?
Common side effects include nausea, diarrhea, headache. Serious but rare side effects include pancreatitis and thyroid tumors.
What is the generic name for Victoza?
The generic name for Victoza is Liraglutide. It is manufactured by Novo Nordisk.
Get Your Free Benefits Report
Enter your email to receive a personalized report of every benefit program you may qualify for.
No spam. Unsubscribe anytime.
Compare Victoza
Other GLP-1 Medications
Weekly GLP-1 injection for type 2 diabetes and weight management
WegovyFDA-approved weekly injection for chronic weight management
MounjaroDual-action GIP/GLP-1 injection for type 2 diabetes
ZepboundFDA-approved dual-action injection for chronic weight management
SaxendaDaily GLP-1 injection for weight management
RybelsusFirst oral GLP-1 tablet for type 2 diabetes
TrulicityWeekly GLP-1 injection for type 2 diabetes